UNSPSC 51373325: Aspirin/caffeine/propoxyphene

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373325 Aspirin/caffeine/propoxyphene, a Commodity code, shows minimal alignment with state and local procurement activity. The single recent opportunity tagged under this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and safe drug deactivation systems, products unrelated to the aspirin/caffeine/propoxyphene combination the code nominates. The mismatch suggests either a data-entry error in the county's procurement system or a deliberately broad tagging decision that does not reflect genuine buying activity in this specific pharmaceutical commodity class.

The Seminole County opportunity, posted June 30, 2026 with responses due July 26, 2023, requests 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders must submit electronically, include all shipping and delivery costs, hold drug-free workplace certification and E-Verify compliance, and maintain workers' compensation and commercial general liability insurance. The contract carries a two-year initial term with a one-year renewal option and a three-month probationary period allowing termination for any cause. The procurement does not cite set-aside designations and may be FEMA-funded, triggering additional federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. No other recent state or local opportunities appear under this code; if your firm pursues pharmaceutical procurement with state and local bodies, verify the correct UNSPSC commodity codes before targeting this category, as current activity does not support sustained pursuit under 51373325.